Premier Alternatives

Cellular Intelligence

Boston, MA · Founded 2023 · Privately Held (backing)

Developer of a biotechnology platform designed to transform medical treatments, diseases, and therapeutic research approaches. Cellular Intelligence is based in Boston, MA and was founded in 2023. Its last reported valuation was $165 million in Aug 2025. It has raised $70.3 million.

Last reported valuation
$165.0M
Oct 2026
Priced at
—
Total raised
$70.3M
Last round
—

Cellular Intelligence key facts

as of Oct 2026
  • Developer of a biotechnology platform designed to transform medical treatments, diseases, and therapeutic research approaches.
  • Cellular Intelligence is valued at approximately $165.0M as of Oct 2026 (last reported valuation).
  • It has raised $70.3M; the latest was Early Stage VC ($60.0M) in Aug 2025.
  • Notable investors include Khosla Ventures, Samsung NEXT Ventures, Harvard Innovation Launch Lab, Lerer Hippeau, Dhuna Ventures — 30 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$165.0M

Cellular Intelligence's last reported valuation, Aug 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Cellular Intelligence with a free account
  • ·The complete investor list: 30 names
  • ·Watch Cellular Intelligence: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cellular Intelligence funding rounds

No rounds on record

No funding rounds for Cellular Intelligence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Cellular Intelligence valuation

Cellular Intelligence's last reported valuation was $165 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.

Cellular Intelligence investors

30 investors are on record for Cellular Intelligence, including Khosla Ventures, Samsung NEXT Ventures, Harvard Innovation Launch Lab and Lerer Hippeau. By type, the record holds 13 venture capital firms.

About Cellular Intelligence

Developer of a biotechnology platform designed to transform medical treatments, diseases, and therapeutic research approaches. The company's platform utilizes artificial intelligence to integrate and analyze vast amounts of biological, genetic, and clinical data to uncover insights into diseases, cell functions, and treatment responses, enabling research and pharmaceutical companies to accelerate the development and optimization of cell therapies.

Sector
Healthcare
HQ
Boston, MA, United States
Founded
2023
Employees
42
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.